Scott T. Rottinghaus, Chief Medical Officer: Enanta Pharmaceuticals ENTA Sell · Filed 25/12/05

Trade details

Type: Insider sale
Amount: $11,355.54
Shares · price: 798 sh · $14.23 a share
Held after: 21,792 sh
Stock: Enanta Pharmaceuticals ENTA
Person: Scott T. RottinghausChief Medical Officer
Trade date: 25/12/05
Filed: 25/12/05
Days to filing: 0 days

Sold 3.5% of holdings

Share of holding sold: 3.5%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/05~01/04

Scott T. Rottinghaus's recent trades

Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$6,980
866 sh
$6,980
Filed 24/12/10
Traded 24/12/06
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$91.8K
5,375 sh
$91.8K
Filed 24/07/15
Traded 24/07/15
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$64.8K
4,299 sh
$64.8K
Filed 24/07/15
Traded 24/07/11
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$34.2K
2,271 sh
$34.2K
Filed 24/07/15
Traded 24/07/12
Scott T. RottinghausSr. VP & CMO
SellEnanta Pharmaceuticals
Sell
Enanta Pharmaceuticals
ENTA
$5,142
534 sh
$5,142
Filed 23/12/06
Traded 23/12/05